Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neogen (NEOG) Long-Term Debt Issuances (2010 - 2012)

Neogen's quarterly Long-Term Debt Issuances came in at $104000.0 in Q1 2012, up 136.36% year-on-year from $44000.0 in Q1 2011, and up 113.54% quarter-over-quarter from -$768000.0 in Q4 2011.

Neogen has reported Long-Term Debt Issuances for 3 years, with the latest figure at $104000.0 in Q1 2012.

  • For the quarter ending Q1 2012, Long-Term Debt Issuances rose 136.36% year-over-year to $104000.0; the trailing twelve-month figure through Feb 2012 stood at -$706000.0 (changed N/A YoY), and the FY2025 full-year result was $450.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q1 2012 stood at $104000.0, up from -$768000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $140000.0 in Q3 2010, with the low at -$768000.0 in Q4 2011.
  • Average Long-Term Debt Issuances over 3 years is -$74833.3, with a median of $74000.0 recorded in 2011.
  • Year-over-year, Long-Term Debt Issuances tumbled 756.41% in 2011 and soared 136.36% in 2012.
  • Tracing NEOG's Long-Term Debt Issuances over 3 years: stood at $117000.0 in 2010, then plunged by 756.41% to -$768000.0 in 2011, then surged by 113.54% to $104000.0 in 2012.
  • The last three Long-Term Debt Issuances figures came in at $104000.0 (Q1 2012), -$768000.0 (Q4 2011), and -$86000.0 (Q3 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Neogen 1.94 Bn 1.78 Bn 99.00 Mn -

Historic Data

Download Data 🔒
DateValue
Feb 29, 2012 104,000.00
Feb 29, 2012 104,000.00
Nov 30, 2011 -768,000.00
Nov 30, 2011 -768,000.00
Aug 31, 2011 -86,000.00
Aug 31, 2011 -86,000.00
Feb 28, 2011 44,000.00
Feb 28, 2011 44,000.00
Nov 30, 2010 117,000.00
Nov 30, 2010 117,000.00
Aug 31, 2010 140,000.00
Aug 31, 2010 140,000.00